
Latest insights

Servaas Michielssens, Linden Thomson, Equities
In 2000, Candriam took an audacious gamble : to invest in biotechnology, a field that was still little-followed by analysts at the time.
Popular Right Now

Equities, Ken Van Weyenberg
Reshoring: A Catalyst for Smart Manufacturing
Global manufacturers are navigating a highly challenging environment marked by tariffs, trade conflicts and new alliances, supply chain disruptions, and rising geopolitical tensions.

Servaas Michielssens, Linden Thomson, Equities
25 Years of Innovation in Biotechnology: a Strategy Always at the Cutting Edge
In 2000, Candriam took an audacious gamble : to invest in biotechnology, a field that was still little-followed by analysts at the time.

Johan Van der Biest, AI, ESG, SRI
Hello ChatGPT: Will Artificial Intelligence (“AI”) continue to surprise the world?
AI is accelerating scientific research, infrastructure development, communications and finance, as well as contributing to the fight against climate change

ESG, SRI, Healthcare, Servaas Michielssens, Linden Thomson
Time to Re-engage with Healthcare?
Healthcare share prices tend to reflect some trepidation leading up to and shortly after the US presidential elections, yet for the last five elections the sector outperformed in the 12 months following the election.

Equities, Geoffroy Goenen, Jean-Baptiste Sergeant
Let’s not neglect European equities!
Since the US presidential elections, US equities have been on an uptrend driven by a certain optimism, as the expectation of tax cuts and deregulation have fuelled the hope of accelerated corporate earnings growth.

Outlook 2025, Nadège Dufossé
Asset allocation in 2025: Between optimism and uncertainty
The year 2024 ends with significant economic disparities between regions. Which asset classes should be favoured for 2025?

Outlook 2025, Steeve Brument, Bertrand Dardenne
M&A: Triple Trends for 2025?
As we head into 2025, the stars seem to be aligning for a revival of mergers and acquisitions, creating a fertile environment for investors seeking new opportunities. Merger arbitrage strategies attempt to capitalize on M&A activity by using a structured approach returns.

Outlook 2025, Alix Chosson, Tanguy Cornet
2025: the swan song for global climate action?
2024 concluded as another annus horribilis for climate action, with COP29 blowing “hot air”, reinforced geopolitical tensions overshadowing the climate crisis, and the re-election of Donald Trump in the U.S. We only have a couple of years left before spending the totality of the +1.5°C carbon budget. How will the recent political changes and global geopolitical tensions impact the transition?
Explore
Find the latest research papers. Easily filter by tags such as authors, themes, and formats to access the information most relevant to you. Explore and enhance your understanding with Candriam's trusted research.

Research Paper, ESG, SRI, Fixed Income, Dany da Fonseca, Vincent Compiègne, Patrick Zeenni
Beyond the Green Bond?
Ready for change?

Research Paper, Johann Mauchand, Alternative Investments, Asset Allocation
Alternative strategies: Is 40/30/30 the new 60/40?
2022 was a landmark year for monetary policy, with Central banks shifting priority from supporting growth to taming inflation.

Research Paper, Maïa Ferrand, ESG, SRI
Investing in Natural Capital: Challenges and Opportunities
Defined as the “stock of renewable and non-renewable natural resources (e.g.,plants, animals, air, water, soils, minerals) that combine to yield a flow of benefits to people” by the Natural Capital Coalition, natural capital is at the source of everything that surrounds us.

Lucia Meloni, Hien Nguyen, Vincent Compiègne, ESG, SRI, Research Paper
Corporate governance in emerging markets: what’s behind the curtain ?
There are several examples of emerging markets where corporate governance standards and ESG disclosure have evolved in recent years, among which China, India, South Korea, Taiwan…
Loading...